Late Immune Recovery in Children Treated for Malignant Diseases

[1]  R. Pinkerton.  Continuing challenges in childhood non‐Hodgkin's lymphoma , 2005, British journal of haematology.

[2]  M. Hanada,et al.  Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy , 2005, Cancer Immunology, Immunotherapy.

[3]  Malcolm A. Smith,et al.  An Overview of Progress in Childhood Cancer Survival , 2004, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[4]  A. Oshima,et al.  Survival rates of childhood cancer patients in Osaka, Japan. , 2004, Japanese journal of clinical oncology.

[5]  M. Schrappe.  Evolution of BFM trials for childhood ALL. , 2004, Annals of hematology.

[6]  D. Reinhardt,et al.  Impact of Conventional Chemotherapy on Levels of Antibodies Against Vaccine-Preventable Diseases in Children Treated for Cancer , 2003, Scandinavian journal of infectious diseases.

[7]  D. Douek,et al.  Early reconstitution of the T‐cell repertoire after non‐myeloablative peripheral blood stem cell transplantation is from post‐thymic T‐cell expansion and is unaffected by graft‐versus‐host disease or mixed chimaerism , 2003, British journal of haematology.

[8]  M. Vasef,et al.  Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation , 2003, Bone Marrow Transplantation.

[9]  A. Chybicka,et al.  A prospective analysis of immune recovery in children following allogeneic transplantation of t-cell-depleted or non-T-cell-depleted hematopoietic cells from HLA-disparate family donors. , 2003, Transplantation proceedings.

[10]  A. Pession,et al.  Gonadal function and pubertal development after treatment of a childhood malignancy. , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[11]  M. Ussowicz,et al.  Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery , 2002, British journal of haematology.

[12]  J. Auletta,et al.  Immune reconstitution in pediatric stem-cell transplantation. , 2001, Frontiers in bioscience : a journal and virtual library.

[13]  J. Petersen,et al.  Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation , 2001, Clinical endocrinology.

[14]  B. Meister,et al.  Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy. , 2001, Medical and pediatric oncology.

[15]  Ó. Jónsson,et al.  IMMUNOGLOBULIN CLASS AND SUBCLASS CONCENTRATIONS AFTER TREATMENT OF CHILDHOOD LEUKEMIA , 2001, Pediatric hematology and oncology.

[16]  J. Argente,et al.  Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study. , 2000, The Journal of clinical endocrinology and metabolism.

[17]  C. Schwartz.  Long-term survivors of childhood cancer: the late effects of therapy. , 1999, The oncologist.

[18]  N. Winick,et al.  Immune Recovery in Children With Malignancy After Cessation of Chemotherapy , 1998, Journal of pediatric hematology/oncology.

[19]  G. Sirchia,et al.  Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. , 1996, Bone marrow transplantation.

[20]  V. Bonagura,et al.  Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy. , 1995, The Journal of pediatrics.

[21]  T. Pelliniemi,et al.  Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors. , 1995, Medical and pediatric oncology.

[22]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[23]  M. Jenney.  Principles and Practice of Pediatric Oncology , 1994 .

[24]  T. Pelliniemi,et al.  Recovery of blood lymphocytes and serum immunoglobulins after treatment of solid tumors in children. , 1994, Pediatric hematology and oncology.

[25]  T. Salmi,et al.  Recovery of blood B‐lymphocytes and serum immunoglobulins after chemotherapy for childhood acute lymphoblastic leukemia , 1992, Cancer.

[26]  R. Gale,et al.  Maintenance chemotherapy and cure of childhood acute lymphoblastic leukaemia , 1991, The Lancet.

[27]  T. Eckschlager,et al.  Cell-mediated immunity in children with Hodgkin's and non-Hodgkin's lymphomas. , 1991, Pediatric hematology and oncology.

[28]  藪原 明彦.  A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia , 1991 .

[29]  A. Komiyama,et al.  Decrease in number of CD16(Leu 11)+CD45RA(2H4)+ cells and defective production of natural killer cytotoxic factor in childhood acute lymphoblastic leukemia. , 1991, Leukemia research.

[30]  E. Coligan.  Current protocols in immunology , 1991 .

[31]  N. Jaffe,et al.  Long-term effects of radiotherapy in childhood and adolescence. , 1990, American journal of surgery.

[32]  S. Jackson,et al.  Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers. , 1990, Archives of disease in childhood.

[33]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .

[34]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[35]  N. Abeling,et al.  Numerical changes in the various peripheral white blood cells in children as a result of antineoplastic therapy. , 1984, Acta haematologica.

[36]  Roger L. Black,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics , 1991 .

[37]  D. Doniach.  Laboratory Diagnosis of Immunologic Disorders , 1976 .

[38]  T. Stewart,et al.  The effect of immunosuppressive chemotherapy on immune function in patients with malignant disease , 1976, Cancer.

[39]  L. Hektoen,et al.  The effect of mustard gas (dichlorethyl-sulphid) on antibody formation , 1921 .